Sign in to view content

Twelve Month Safety and Efficacy Outcomes from a Phase 2 Study of APL-2 in Patients with Geographic Atrophy

David S. Boyer, MD

Video
Published 2017

Related

ARMD With Geographic Atrophy, Peripheral Degeneration
James B. Soque, CRA, OCT-C, COA, FOPS
Pamela Ann Weber, MD
Retina Image Bank: Images of the Week
2013
Episode 162: April 2019 Retinal Physician Preview Discussion of AMD Topics with Dr. Margaret Greven and Dr. M. Ali Khan
Jayanth Sridhar, MD
Member Podcasts
2018
Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy
Michael J Allingham, MD, PhD
Annual Meeting Talks
2022

Category: AMD-Neovascular

See more